Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012

Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β-haemolytic...

Full description

Saved in:
Bibliographic Details
Published inEpidemiology and infection Vol. 143; no. 4; pp. 864 - 872
Main Authors IKEBE, T., TOMINAGA, K., SHIMA, T., OKUNO, R., KUBOTA, H., OGATA, K., CHIBA, K., KATSUKAWA, C., OHYA, H., TADA, Y., OKABE, N., WATANABE, H., OGAWA, M., OHNISHI, M.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.03.2015
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Clindamycin - pharmacology
Disease control
Drug Resistance, Bacterial - genetics
Erythromycin - pharmacology
Female
Genes
Genotype
Genotype & phenotype
Genotypes
Human subjects
Humans
Infant
Infectious diseases
Japan - epidemiology
Male
Microbial Sensitivity Tests
Middle Aged
Original Papers
Pathogens
Penicillin
Prevalence
Proteins
Shock, Septic - epidemiology
Shock, Septic - microbiology
Streptococcal Infections - epidemiology
Streptococcal Infections - microbiology
Streptococcus
Streptococcus infections
Streptococcus pyogenes - drug effects
Streptococcus pyogenes - genetics
Streptococcus pyogenes - isolation & purification
Toxic shock syndrome
Working groups
Young Adult
Japan
group A streptococcus
emm genotype
streptococcal toxic shock syndrome
Antibiotic resistance
Online AccessGet full text
ISSN0950-2688
1469-4409
1469-4409
DOI10.1017/S0950268814001265

Cover

Abstract Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60–70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
AbstractList Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60–70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
SUMMARY Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by [beta]-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60-70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β -haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60–70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1 , followed by emm89 , emm12 , emm28 , emm3 , and emm90 . These six genotypes constituted more than 90% of the STSS isolates. The number of emm1 , emm89 , emm12 , and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA -positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by 𝛽-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60–70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by beta -haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60-70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60-70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality. In Japan, appropriate notification measures based on the Infectious Disease Control law are mandatory for cases of STSS caused by β-haemolytic streptococcus. STSS is mainly caused by group A streptococcus (GAS). Although an average of 60-70 cases of GAS-induced STSS are reported annually, 143 cases were recorded in 2011. To determine the reason behind this marked increase, we characterized the emm genotype of 249 GAS isolates from STSS patients in Japan from 2010 to 2012 and performed antimicrobial susceptibility testing. The predominant genotype was found to be emm1, followed by emm89, emm12, emm28, emm3, and emm90. These six genotypes constituted more than 90% of the STSS isolates. The number of emm1, emm89, emm12, and emm28 isolates increased concomitantly with the increase in the total number of STSS cases. In particular, the number of mefA-positive emm1 isolates has escalated since 2011. Thus, the increase in the incidence of STSS can be attributed to an increase in the number of cases associated with specific genotypes.
Author TOMINAGA, K.
KATSUKAWA, C.
OKUNO, R.
KUBOTA, H.
OGATA, K.
OGAWA, M.
SHIMA, T.
OKABE, N.
OHNISHI, M.
CHIBA, K.
TADA, Y.
WATANABE, H.
IKEBE, T.
OHYA, H.
Author_xml – sequence: 1
  givenname: T.
  surname: IKEBE
  fullname: IKEBE, T.
  email: tdikebe@nih.go.jp
  organization: Department of Bacteriology I, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan
– sequence: 2
  givenname: K.
  surname: TOMINAGA
  fullname: TOMINAGA, K.
  organization: Department of Public Health Sciences, Yamaguchi Prefectural Institute of Public Health and Environment, Yamaguchi, Japan
– sequence: 3
  givenname: T.
  surname: SHIMA
  fullname: SHIMA, T.
  organization: Department of Bacteriology, Toyama Institute of Health, Toyama, Japan
– sequence: 4
  givenname: R.
  surname: OKUNO
  fullname: OKUNO, R.
  organization: Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
– sequence: 5
  givenname: H.
  surname: KUBOTA
  fullname: KUBOTA, H.
  organization: Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan
– sequence: 6
  givenname: K.
  surname: OGATA
  fullname: OGATA, K.
  organization: Laboratory of Microbiology, Oita Prefectural Institute of Health and Environment, Oita, Japan
– sequence: 7
  givenname: K.
  surname: CHIBA
  fullname: CHIBA, K.
  organization: Department of Microbiology, Fukushima Institute of Public Health, Fukushima, Japan
– sequence: 8
  givenname: C.
  surname: KATSUKAWA
  fullname: KATSUKAWA, C.
  organization: Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka, Japan
– sequence: 9
  givenname: H.
  surname: OHYA
  fullname: OHYA, H.
  organization: Division of Microbiology, Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan
– sequence: 10
  givenname: Y.
  surname: TADA
  fullname: TADA, Y.
  organization: Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 11
  givenname: N.
  surname: OKABE
  fullname: OKABE, N.
  organization: Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 12
  givenname: H.
  surname: WATANABE
  fullname: WATANABE, H.
  organization: Department of Bacteriology I, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan
– sequence: 13
  givenname: M.
  surname: OGAWA
  fullname: OGAWA, M.
  organization: Department of Bacteriology I, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan
– sequence: 14
  givenname: M.
  surname: OHNISHI
  fullname: OHNISHI, M.
  organization: Department of Bacteriology I, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25703404$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1TAQhS1URG8LP4AFyBIbNoGx4-eyqngUVWIBrCNfZ1JySeJgO4gu-O843AtURcDCGsvnO2c8mhNyNIUJCXnI4BkDpp-_AyuBK2OYAGBcyTtkw4SylRBgj8hmlatVPyYnKe0AwHKj75FjLjXUAsSGfLuYfESXsKVzxC9uwMkjDR29imGZ6RlNOeKcgw_eL4n2KQwuY7lMNxU30By-9p6mj8F_oul6amMYkfoS_IN942Y30a48Ug4MCr1Wfp_c7dyQ8MGhnpIPL1-8P39dXb59dXF-dll5BTpXrTFC1axubV2OVdI4XjMQqLSynVHbliMYL7cgvRbG2VaDBGbQmw6Yt_UpebrPnWP4vGDKzdgnj8PgJgxLapgyIIQWpcf_UWkE01LLgj65he7CEqcySKE0Z2C4XAMfH6hlO2LbzLEfXbxufu6gAGwP-BhSitj9Qhg0656bP_ZcPPqWx_fZ5T5MObp--Kfz0d65SznE379RsshWF70-JLtxG_v2Cm9M9dfU73rIwOU
CitedBy_id crossref_primary_10_1128_mBio_01378_15
crossref_primary_10_1016_j_jiac_2019_10_010
crossref_primary_10_1016_j_anpedi_2018_12_017
crossref_primary_10_1007_s10096_019_03625_9
crossref_primary_10_1097_IM9_0000000000000038
crossref_primary_10_7759_cureus_80806
crossref_primary_10_1111_ped_14349
crossref_primary_10_1002_ams2_634
crossref_primary_10_1016_j_jccase_2024_09_009
crossref_primary_10_1016_S2666_5247_23_00318_X
crossref_primary_10_1038_srep28761
crossref_primary_10_1016_j_ijmm_2021_151496
crossref_primary_10_1186_s12879_017_2870_2
crossref_primary_10_1186_s12941_018_0282_9
crossref_primary_10_7759_cureus_28055
crossref_primary_10_1159_000504002
crossref_primary_10_1186_s12866_016_0714_7
crossref_primary_10_1016_j_jiac_2019_01_006
crossref_primary_10_1099_mic_0_000206
crossref_primary_10_1016_j_jiac_2018_10_004
crossref_primary_10_1007_s12185_022_03339_3
crossref_primary_10_1128_AEM_01428_19
crossref_primary_10_1016_j_anpede_2018_12_007
crossref_primary_10_1016_j_jiac_2017_09_013
crossref_primary_10_1136_bcr_2017_220847
crossref_primary_10_1093_mrcr_rxae001
crossref_primary_10_1016_j_jiac_2015_07_011
crossref_primary_10_3390_antibiotics13040360
crossref_primary_10_7883_yoken_JJID_2015_334
crossref_primary_10_1016_j_jiac_2019_05_001
crossref_primary_10_1016_j_meegid_2022_105258
crossref_primary_10_2169_internalmedicine_6290_20
crossref_primary_10_1093_infdis_jiw468
crossref_primary_10_1111_irv_12658
crossref_primary_10_1111_1348_0421_12577
crossref_primary_10_1111_1348_0421_12334
crossref_primary_10_1002_ams2_617
crossref_primary_10_1093_jac_dkae462
crossref_primary_10_3346_jkms_2024_39_e154
crossref_primary_10_1016_j_jiac_2024_11_010
crossref_primary_10_1093_jacamr_dlaf017
crossref_primary_10_1016_j_idcr_2016_09_002
crossref_primary_10_1016_j_idcr_2024_e01927
crossref_primary_10_1007_s10096_024_05015_2
crossref_primary_10_1093_ofid_ofx042
crossref_primary_10_1099_jmm_0_000622
crossref_primary_10_1016_j_jos_2020_04_007
crossref_primary_10_1038_s41588_018_0343_1
crossref_primary_10_7883_yoken_JJID_2020_006
crossref_primary_10_1099_jmm_0_000460
crossref_primary_10_1016_j_ijid_2024_01_021
crossref_primary_10_3390_pathogens10020248
Cites_doi 10.2807/1560-7917.ES2013.18.33.20556
10.1007/978-94-007-0940-9_12
10.1086/318543
10.1111/1469-0691.12134
10.1099/jmm.0.042309-0
10.2165/11634180-000000000-00000
10.1146/annurev.iy.04.040186.002443
10.1001/jama.1993.03500030082037
10.1093/clinids/14.1.2
10.1007/s10096-011-1226-x
10.1001/jama.1993.03500030088038
10.1128/AAC.48.9.3559-3562.2004
10.2807/ese.16.41.19988-en
10.1016/j.vaccine.2012.09.045
10.1128/JCM.34.4.953-958.1996
10.1016/j.tim.2010.02.007
10.1128/JCM.35.12.3220-3224.1997
10.1086/515012
10.1086/432473
10.7883/yoken.63.372
10.1016/j.jpeds.2003.10.025
10.1128/AAC.43.9.2144
10.1128/AAC.13.3.399
10.1038/11369
10.1128/AAC.40.11.2562
10.7883/yoken.63.304
ContentType Journal Article
Contributor Tsuchiya, Y
Ishida, H
Takenuma, H
Tanaka, S
Nakajima, H
Sasano, A
Sakamoto, Y
Takeda, Y
Matsumoto, Y
Takai, K
Kasahara, H
Kanazawa, Y
Ueno, H
Kawai, Y
Hanahara, Y
Hachisu, Y
Iwabuchi, K
Konno, T
Shimizu, M
Takagi, T
Asai, N
Sugimoto, M
Uchida, J
Mori, H
Saito, E
Seto, J
Hosoya, M
Kudaka, J
Shimada, N
Moroishi, S
Goto, I
Naitou, H
Tada, N
Tanabe, S
Morimoto, Y
Fukushima, K
Kojima, Y
Tomita, A
Fujito, A
Akanuma, M
Kodama, M
Kurosaki, M
Matsumoto, M
Kobayashi, G
Matsumoto, J
Kawanishi, S
Kuwata, A
Nagashima, C
Contributor_xml – sequence: 1
  givenname: Y
  surname: Morimoto
  fullname: Morimoto, Y
– sequence: 2
  givenname: Y
  surname: Sakamoto
  fullname: Sakamoto, Y
– sequence: 3
  givenname: H
  surname: Takenuma
  fullname: Takenuma, H
– sequence: 4
  givenname: K
  surname: Iwabuchi
  fullname: Iwabuchi, K
– sequence: 5
  givenname: T
  surname: Konno
  fullname: Konno, T
– sequence: 6
  givenname: I
  surname: Goto
  fullname: Goto, I
– sequence: 7
  givenname: J
  surname: Seto
  fullname: Seto, J
– sequence: 8
  givenname: M
  surname: Hosoya
  fullname: Hosoya, M
– sequence: 9
  givenname: G
  surname: Kobayashi
  fullname: Kobayashi, G
– sequence: 10
  givenname: T
  surname: Takagi
  fullname: Takagi, T
– sequence: 11
  givenname: H
  surname: Naitou
  fullname: Naitou, H
– sequence: 12
  givenname: C
  surname: Nagashima
  fullname: Nagashima, C
– sequence: 13
  givenname: Y
  surname: Kawai
  fullname: Kawai, Y
– sequence: 14
  givenname: N
  surname: Shimada
  fullname: Shimada, N
– sequence: 15
  givenname: Y
  surname: Hachisu
  fullname: Hachisu, Y
– sequence: 16
  givenname: Y
  surname: Matsumoto
  fullname: Matsumoto, Y
– sequence: 17
  givenname: Y
  surname: Kojima
  fullname: Kojima, Y
– sequence: 18
  givenname: A
  surname: Sasano
  fullname: Sasano, A
– sequence: 19
  givenname: H
  surname: Kasahara
  fullname: Kasahara, H
– sequence: 20
  givenname: K
  surname: Takai
  fullname: Takai, K
– sequence: 21
  givenname: A
  surname: Tomita
  fullname: Tomita, A
– sequence: 22
  givenname: Y
  surname: Tsuchiya
  fullname: Tsuchiya, Y
– sequence: 23
  givenname: H
  surname: Ueno
  fullname: Ueno, H
– sequence: 24
  givenname: M
  surname: Akanuma
  fullname: Akanuma, M
– sequence: 25
  givenname: M
  surname: Matsumoto
  fullname: Matsumoto, M
– sequence: 26
  givenname: K
  surname: Fukushima
  fullname: Fukushima, K
– sequence: 27
  givenname: N
  surname: Asai
  fullname: Asai, N
– sequence: 28
  givenname: M
  surname: Shimizu
  fullname: Shimizu, M
– sequence: 29
  givenname: H
  surname: Mori
  fullname: Mori, H
– sequence: 30
  givenname: M
  surname: Sugimoto
  fullname: Sugimoto, M
– sequence: 31
  givenname: N
  surname: Tada
  fullname: Tada, N
– sequence: 32
  givenname: E
  surname: Saito
  fullname: Saito, E
– sequence: 33
  givenname: S
  surname: Tanaka
  fullname: Tanaka, S
– sequence: 34
  givenname: S
  surname: Kawanishi
  fullname: Kawanishi, S
– sequence: 35
  givenname: S
  surname: Tanabe
  fullname: Tanabe, S
– sequence: 36
  givenname: A
  surname: Kuwata
  fullname: Kuwata, A
– sequence: 37
  givenname: Y
  surname: Kanazawa
  fullname: Kanazawa, Y
– sequence: 38
  givenname: Y
  surname: Hanahara
  fullname: Hanahara, Y
– sequence: 39
  givenname: M
  surname: Kurosaki
  fullname: Kurosaki, M
– sequence: 40
  givenname: H
  surname: Nakajima
  fullname: Nakajima, H
– sequence: 41
  givenname: Y
  surname: Takeda
  fullname: Takeda, Y
– sequence: 42
  givenname: M
  surname: Kodama
  fullname: Kodama, M
– sequence: 43
  givenname: J
  surname: Uchida
  fullname: Uchida, J
– sequence: 44
  givenname: H
  surname: Ishida
  fullname: Ishida, H
– sequence: 45
  givenname: J
  surname: Matsumoto
  fullname: Matsumoto, J
– sequence: 46
  givenname: A
  surname: Fujito
  fullname: Fujito, A
– sequence: 47
  givenname: S
  surname: Moroishi
  fullname: Moroishi, S
– sequence: 48
  givenname: J
  surname: Kudaka
  fullname: Kudaka, J
Copyright Copyright © Cambridge University Press 2014
Cambridge University Press 2014
Copyright_xml – notice: Copyright © Cambridge University Press 2014
– notice: Cambridge University Press 2014
CorporateAuthor the Working Group for Beta-haemolytic Streptococci in Japan
Working Group for Beta-haemolytic Streptococci in Japan
CorporateAuthor_xml – name: the Working Group for Beta-haemolytic Streptococci in Japan
– name: Working Group for Beta-haemolytic Streptococci in Japan
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7U9
7X7
7XB
88A
88E
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AN0
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7N
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1017/S0950268814001265
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
ProQuest Central Student
CrossRef

Bacteriology Abstracts (Microbiology B)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Biology
DocumentTitleAlternate Molecular epidemiology of STSS isolates
T. Ikebe and others
EISSN 1469-4409
EndPage 872
ExternalDocumentID 3650528191
25703404
10_1017_S0950268814001265
26512697
Genre Journal Article
Feature
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
-1D
-1F
-2P
-2V
-E.
-~6
-~N
-~X
..I
.FH
.GJ
09C
09E
0E1
0R~
29G
3O-
3V.
4.4
53G
5GY
5VS
6PF
6~7
74X
74Y
7RV
7X7
7~V
88A
88E
8C1
8FE
8FH
8FI
8FJ
8R4
8R5
9M5
AAAZR
AABES
AABWE
AACGO
AACJH
AAEED
AAGFV
AAGKA
AAKDD
AAKTX
AAMNQ
AANCE
AANRG
AARAB
AASVR
AATID
AAUIS
AAUKB
AAWTL
ABBHK
ABBXD
ABFBI
ABITZ
ABKKG
ABKMT
ABLJU
ABMWE
ABMYL
ABOCM
ABPLY
ABQTM
ABQWD
ABROB
ABTCQ
ABTLG
ABUWG
ABVFV
ABWCF
ABXAU
ABXSQ
ABZCX
ABZUI
ACBEK
ACBMC
ACCHT
ACETC
ACGFS
ACIMK
ACMRT
ACPRK
ACQFJ
ACREK
ACUIJ
ACUYZ
ACWGA
ACZBM
ACZUX
ACZWT
ADACV
ADAZD
ADBBV
ADDNB
ADFEC
ADGEJ
ADKIL
ADOCW
ADOVH
ADOVT
ADULT
ADVJH
ADZLD
AEBAK
AEBPU
AEHGV
AEMTW
AENCP
AENEX
AENGE
AEUPB
AEXZC
AEYHU
AEYYC
AFFNX
AFFUJ
AFKQG
AFKRA
AFKSM
AFLOS
AFLVW
AFRAH
AFRIC
AFUTZ
AGABE
AGJUD
AGLWM
AGOOT
AHIPN
AHLTW
AHMBA
AHQXX
AHRGI
AIGNW
AIHIV
AIOIP
AISIE
AJ7
AJCYY
AJPFC
AJQAS
AKZCZ
ALMA_UNASSIGNED_HOLDINGS
ALVPG
ALWZO
AN0
ANPSP
AOIJS
AQJOH
AQVQM
ARABE
ARZZG
ATUCA
AUXHV
AYIQA
AZGZS
BBLKV
BBNVY
BCGOX
BENPR
BESQT
BGHMG
BHPHI
BJBOZ
BKEYQ
BLZWO
BMAJL
BNQBC
BPHCQ
BQFHP
BRIRG
BVXVI
C0O
CAG
CBIIA
CCPQU
CCQAD
CCUQV
CDIZJ
CFAFE
CFBFF
CGQII
CHEAL
CJCSC
COF
CS3
DCCCD
DNJUQ
DOHLZ
DOOOF
DU5
DWIUU
EBS
EGQIC
EJD
EMOBN
EX3
F5P
FYUFA
GROUPED_DOAJ
HCIFZ
HG-
HGD
HMCUK
HQ3
HST
HTVGU
HYE
HZ~
I.6
I.7
I.9
IKXGN
IOEEP
IOO
IPYYG
IS6
I~P
J36
J38
J3A
JAAYA
JBMMH
JENOY
JHFFW
JHPGK
JKPOH
JKQEH
JLS
JLXEF
JPM
JQKCU
JSG
JSODD
JST
JVRFK
KAFGG
KC5
KCGVB
KFECR
L7B
L98
LHUNA
LK8
LW7
M-V
M0L
M1P
M7P
M7~
M8.
NAPCQ
NIKVX
NMFBF
NZEOI
O9-
OK1
OVD
OYBOY
P2P
PQQKQ
PROAC
PSQYO
Q2X
RAMDC
RCA
RIG
ROL
RPM
RR0
S6-
S6U
SA0
SAAAG
SY4
T9M
TEORI
UCJ
UKHRP
UT1
UU6
WFFJZ
WH7
WOW
WQ3
WXU
WXY
WYP
ZDLDU
ZGI
ZJOSE
ZMEZD
ZXP
ZYDXJ
~02
~V1
AAFWJ
AATMM
ABGDZ
ABVKB
ABVZP
ABXHF
ACAJB
ACDLN
ACHIC
ADQXQ
AEUYN
AFPKN
AFZFC
AKMAY
ALIPV
IPSME
PHGZM
PHGZT
AAKNA
AAYXX
ABHFL
ACEJA
ACOZI
ACRPL
ADNMO
AEMFK
AGQPQ
ANOYL
CITATION
M48
AGKLZ
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
H94
K9.
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c607t-d8846313d933d99658a23104e6769f86bd2e08c5b05c748a9d705018ec8f01c93
IEDL.DBID 7X7
ISSN 0950-2688
1469-4409
IngestDate Wed Jul 30 11:22:49 EDT 2025
Thu Jul 10 17:34:34 EDT 2025
Fri Jul 25 11:03:13 EDT 2025
Thu Apr 03 07:08:52 EDT 2025
Thu Apr 24 22:52:34 EDT 2025
Tue Jul 01 01:45:18 EDT 2025
Thu Jul 03 22:32:27 EDT 2025
Wed Mar 13 05:53:03 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords group A streptococcus
emm genotype
streptococcal toxic shock syndrome
Antibiotic resistance
Language English
License https://www.cambridge.org/core/terms
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-d8846313d933d99658a23104e6769f86bd2e08c5b05c748a9d705018ec8f01c93
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F1600280601E375F746D9C9BE9F39BB4/S0950268814001265a.pdf/div-class-title-increased-prevalence-of-group-a-streptococcus-isolates-in-streptococcal-toxic-shock-syndrome-cases-in-japan-from-2010-to-2012-div.pdf
PMID 25703404
PQID 1672108251
PQPubID 6286
PageCount 9
ParticipantIDs proquest_miscellaneous_1680447431
proquest_miscellaneous_1658417575
proquest_journals_1672108251
pubmed_primary_25703404
crossref_primary_10_1017_S0950268814001265
crossref_citationtrail_10_1017_S0950268814001265
jstor_primary_26512697
cambridge_journals_10_1017_S0950268814001265
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-03-01
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: 2015-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Cambridge, UK
PublicationPlace_xml – name: Cambridge, UK
– name: England
– name: Cambridge
PublicationTitle Epidemiology and infection
PublicationTitleAlternate Epidemiol. Infect
PublicationYear 2015
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
References Ghosh (2) 2011; 715
Hoe (5) 1999; 5
Ikebe (11) 2010; 63
Steer (10) 2012; 72
Martin (8) 2011; 16
McMillan (3) 2013; 19
Hoge (6) 1993; 269
Beall, Facklam, Thompson (13) 1996; 34
Montes (24) 2011; 30
Eriksson (20) 1998; 27
Meehan (9) 2013; 18
Smeesters, McMillan, Sriprakash (1) 2010; 18
Ikebe (19) 2010; 63
Stevens (7) 1992; 14
Hoe (27) 2001; 183
De Azavedo (17) 1999; 43
Miyamoto (26) 1978; 13
Muller-Eberhard (4) 1986; 4
Sutcliffe (18) 1996; 40
Mejia (14) 1997; 35
Breiman (12) 1993; 269
Patel, Binns, Shulman (21) 2004; 144
Liang (25) 2012; 61
Bingen (23) 2004; 48
Richter (16) 2005; 41
Dale (22) 2013; 31
Mejia (S0950268814001265_ref14) 1997; 35
Martin (S0950268814001265_ref8) 2011; 16
De Azavedo (S0950268814001265_ref17) 1999; 43
Hoe (S0950268814001265_ref5) 1999; 5
S0950268814001265_ref26
S0950268814001265_ref27
S0950268814001265_ref9
S0950268814001265_ref6
S0950268814001265_ref24
S0950268814001265_ref7
S0950268814001265_ref25
S0950268814001265_ref22
S0950268814001265_ref4
Sutcliffe (S0950268814001265_ref18) 1996; 40
S0950268814001265_ref23
S0950268814001265_ref2
S0950268814001265_ref20
S0950268814001265_ref21
S0950268814001265_ref3
S0950268814001265_ref1
Beall (S0950268814001265_ref13) 1996; 34
Ikebe (S0950268814001265_ref11) 2010; 63
S0950268814001265_ref15
Ikebe (S0950268814001265_ref19) 2010; 63
S0950268814001265_ref16
S0950268814001265_ref12
S0950268814001265_ref10
References_xml – volume: 61
  start-page: 975
  year: 2012
  end-page: 983
  ident: 25
  article-title: Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children
  publication-title: Journal of Medical Microbiology
– volume: 715
  start-page: 197
  year: 2011
  end-page: 211
  ident: 2
  article-title: The nonideal coiled coil of M protein and its multifarious functions in pathogenesis
  publication-title: Advances in Experimental Medicine and Biology
– volume: 41
  start-page: 599
  year: 2005
  end-page: 608
  ident: 16
  article-title: Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003
  publication-title: Clinical Infectious Diseases
– volume: 43
  start-page: 2144
  year: 1999
  end-page: 2147
  ident: 17
  article-title: Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 16
  start-page: 19988
  year: 2011
  ident: 8
  article-title: Invasive Group A streptococcal disease in Ireland, 2004 to 2010
  publication-title: Eurosurveillance
– volume: 35
  start-page: 3220
  year: 1997
  end-page: 3224
  ident: 14
  article-title: Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein
  publication-title: Journal of Clinical Microbiology
– volume: 27
  start-page: 1428
  year: 1998
  end-page: 1436
  ident: 20
  article-title: Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome
  publication-title: Clinical Infectious Diseases
– volume: 63
  start-page: 304
  year: 2010
  end-page: 305
  ident: 11
  article-title: Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan
  publication-title: Japanese Journal of Infectious Diseases
– volume: 40
  start-page: 2562
  year: 1996
  end-page: 2566
  ident: 18
  article-title: Detection of erythromycin-resistant determinants by PCR
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 72
  start-page: 1213
  year: 2012
  end-page: 1227
  ident: 10
  article-title: Invasive group A streptococcal disease: epidemiology, pathogenesis and management
  publication-title: Drugs
– volume: 48
  start-page: 3559
  year: 2004
  end-page: 3562
  ident: 23
  article-title: Emergence of macrolide-resistant Streptococcus pyogenes strains in French children
  publication-title: Antimicrobial Agents in Chemotherapy
– volume: 183
  start-page: 633
  year: 2001
  end-page: 639
  ident: 27
  article-title: Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection
  publication-title: Journal of Infectious Diseases
– volume: 269
  start-page: 384
  year: 1993
  end-page: 389
  ident: 6
  article-title: The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study
  publication-title: Journal of the American Medical Association
– volume: 13
  start-page: 399
  year: 1978
  end-page: 404
  ident: 26
  article-title: Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type
  publication-title: Antimicrobial Agents and Chemotherapy
– volume: 4
  start-page: 503
  year: 1986
  end-page: 528
  ident: 4
  article-title: The membrane attack complex of complement
  publication-title: Annual Review of Immunology
– volume: 31
  start-page: B216
  year: 2013
  end-page: 222
  ident: 22
  article-title: Group A streptococcal vaccines: paving a path for accelerated development
  publication-title: Vaccine
– volume: 18
  start-page: 275
  year: 2010
  end-page: 282
  ident: 1
  article-title: The streptococcal M protein: a highly versatile molecule
  publication-title: Trends in Microbiology
– volume: 5
  start-page: 924
  year: 1999
  end-page: 929
  ident: 5
  article-title: Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves
  publication-title: Nature Medicine
– volume: 14
  start-page: 2
  year: 1992
  end-page: 13
  ident: 7
  article-title: Invasive group A streptococcus infections
  publication-title: Clinical Infectious Diseases
– volume: 19
  start-page: E222
  year: 2013
  end-page: 229
  ident: 3
  article-title: Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study
  publication-title: Clinical Microbiology and Infection
– volume: 63
  start-page: 372
  year: 2010
  end-page: 375
  ident: 19
  article-title: Surveillance of severe invasive group G streptococcal infections during 2002–2008 in Japan
  publication-title: Japanese Journal of Infectious Diseases
– volume: 269
  start-page: 390
  year: 1993
  end-page: 391
  ident: 12
  article-title: Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections
  publication-title: Journal of the American Medical Association
– volume: 34
  start-page: 953
  year: 1996
  end-page: 958
  ident: 13
  article-title: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci
  publication-title: Journal of Clinical Microbiology
– volume: 144
  start-page: 68
  year: 2004
  end-page: 74
  ident: 21
  article-title: Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era
  publication-title: Journal of Pediatrics
– volume: 30
  start-page: 1295
  year: 2011
  end-page: 1302
  ident: 24
  article-title: Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates
  publication-title: European Journal of Clinical Microbiology & Infectious Diseases
– volume: 18
  start-page: 20556
  year: 2013
  ident: 9
  article-title: Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013
  publication-title: Eurosurveillance
– ident: S0950268814001265_ref9
  doi: 10.2807/1560-7917.ES2013.18.33.20556
– ident: S0950268814001265_ref2
  doi: 10.1007/978-94-007-0940-9_12
– ident: S0950268814001265_ref27
  doi: 10.1086/318543
– ident: S0950268814001265_ref3
  doi: 10.1111/1469-0691.12134
– ident: S0950268814001265_ref25
  doi: 10.1099/jmm.0.042309-0
– ident: S0950268814001265_ref10
  doi: 10.2165/11634180-000000000-00000
– ident: S0950268814001265_ref4
  doi: 10.1146/annurev.iy.04.040186.002443
– ident: S0950268814001265_ref6
  doi: 10.1001/jama.1993.03500030082037
– ident: S0950268814001265_ref7
  doi: 10.1093/clinids/14.1.2
– ident: S0950268814001265_ref24
  doi: 10.1007/s10096-011-1226-x
– ident: S0950268814001265_ref12
  doi: 10.1001/jama.1993.03500030088038
– ident: S0950268814001265_ref15
– ident: S0950268814001265_ref23
  doi: 10.1128/AAC.48.9.3559-3562.2004
– volume: 16
  start-page: 19988
  year: 2011
  ident: S0950268814001265_ref8
  article-title: Invasive Group A streptococcal disease in Ireland, 2004 to 2010
  publication-title: Eurosurveillance
  doi: 10.2807/ese.16.41.19988-en
– ident: S0950268814001265_ref22
  doi: 10.1016/j.vaccine.2012.09.045
– volume: 34
  start-page: 953
  year: 1996
  ident: S0950268814001265_ref13
  article-title: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.34.4.953-958.1996
– ident: S0950268814001265_ref1
  doi: 10.1016/j.tim.2010.02.007
– volume: 35
  start-page: 3220
  year: 1997
  ident: S0950268814001265_ref14
  article-title: Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.35.12.3220-3224.1997
– ident: S0950268814001265_ref20
  doi: 10.1086/515012
– ident: S0950268814001265_ref16
  doi: 10.1086/432473
– volume: 63
  start-page: 372
  year: 2010
  ident: S0950268814001265_ref19
  article-title: Surveillance of severe invasive group G streptococcal infections during 2002–2008 in Japan
  publication-title: Japanese Journal of Infectious Diseases
  doi: 10.7883/yoken.63.372
– ident: S0950268814001265_ref21
  doi: 10.1016/j.jpeds.2003.10.025
– volume: 43
  start-page: 2144
  year: 1999
  ident: S0950268814001265_ref17
  article-title: Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada
  publication-title: Antimicrobial Agents and Chemotherapy
  doi: 10.1128/AAC.43.9.2144
– ident: S0950268814001265_ref26
  doi: 10.1128/AAC.13.3.399
– volume: 5
  start-page: 924
  year: 1999
  ident: S0950268814001265_ref5
  article-title: Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves
  publication-title: Nature Medicine
  doi: 10.1038/11369
– volume: 40
  start-page: 2562
  year: 1996
  ident: S0950268814001265_ref18
  article-title: Detection of erythromycin-resistant determinants by PCR
  publication-title: Antimicrobial Agents and Chemotherapy
  doi: 10.1128/AAC.40.11.2562
– volume: 63
  start-page: 304
  year: 2010
  ident: S0950268814001265_ref11
  article-title: Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan
  publication-title: Japanese Journal of Infectious Diseases
  doi: 10.7883/yoken.63.304
SSID ssj0009287
Score 2.3476458
Snippet Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high mortality....
SUMMARY Streptococcal toxic shock syndrome (STSS) is a severe invasive infection characterized by the sudden onset of shock, multi-organ failure, and high...
SourceID proquest
pubmed
crossref
jstor
cambridge
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 864
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Clindamycin - pharmacology
Disease control
Drug Resistance, Bacterial - genetics
Erythromycin - pharmacology
Female
Genes
Genotype
Genotype & phenotype
Genotypes
Human subjects
Humans
Infant
Infectious diseases
Japan - epidemiology
Male
Microbial Sensitivity Tests
Middle Aged
Original Papers
Pathogens
Penicillin
Prevalence
Proteins
Shock, Septic - epidemiology
Shock, Septic - microbiology
Streptococcal Infections - epidemiology
Streptococcal Infections - microbiology
Streptococcus
Streptococcus infections
Streptococcus pyogenes - drug effects
Streptococcus pyogenes - genetics
Streptococcus pyogenes - isolation & purification
Toxic shock syndrome
Working groups
Young Adult
SummonAdditionalLinks – databaseName: Cambridge University Press Wholly Gold Open Access Journals
  dbid: IKXGN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-6lMKglLZrV_cLFfY0aqLYsi0_ltJv2petkDdjSzILDDskDmwP-993J9lO19LAHkLAPp-FTh-_s-5-B_BFqCKXSSl9SnL0RZkHfhqa0NdpEkaxDExhS7I8PsW3z-J-HI3XYNzlwlBYZc9xYE_ybX20qaM_HU60i6Exs-E3BAfoQEiibMJVNo6G9NFy2Jogazv-A6wjZhihW7Z-9zC-eVoS8ga2eB4p8UlLd-Jp6aRfaSbGYGKqElTObUnB8M9W5qIZ38epdr-63oatFmiyC9fAHVgz1S5suNKTv3dh032vYy4N6RP8wYWC4tONZtMZUYDTjGd1yWzaB7tglFQybWpcP9ViziY4ZAmlskn18g6-sKl_odr5D1xnWUeHwBQqtrL3uDdXjHJaGB2QozT9B3vwfH31_fLWb0sz-CrmSeNribglHIU6DfFHBDI5AUVhKGK2lHGhA8OligoeqUTIPNUJJ-pAo2TJRyoN92FQ1ZU5AMYDXRRclkKX6K3IsEiFTpVAP6iUaKTcg_O-x7PWuvPMBacl2RtbecA7o2SqpTmnahs_Vz3ytX9k6jg-VgnvW0v3kngNr6eJB8ed6V80M0YPm7zwkQdn_W2cwXQsk1emXpAMgkBEcUm0SkZyIQjtefDZDatlA9qhefh_HXUEH9HAkYunO4ZBM1uYEwRYTXHazpW_64YXXg
  priority: 102
  providerName: Cambridge University Press
Title Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012
URI https://www.cambridge.org/core/product/identifier/S0950268814001265/type/journal_article
https://www.jstor.org/stable/26512697
https://www.ncbi.nlm.nih.gov/pubmed/25703404
https://www.proquest.com/docview/1672108251
https://www.proquest.com/docview/1658417575
https://www.proquest.com/docview/1680447431
Volume 143
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9swED62lsJgjK1bN69d0aBPo2KyLVvy02hLu66jYYwW8hZsSaaFYWeNA9vD_vvuJNtpGctDYpDPjshJp--ku-8ADqSpSq1qzSnJkcu6THiRupTbQqVZrhNX-ZIsl5P8_FpeTLNpv-G26MMqB5voDbVtDe2Rf4xz9FXIn4k_zX9yqhpFp6t9CY3HsEnUZRTSpaZqRbqb-AJ5iCIET3Kth1NNTxmNjdSGDgbaaFpbVtwKD9aoEKb4fwDqF6Kz5_CsR5DsKKj8BTxyzTZshZqSv7fhadiIYyG_6CX8QQtAgefOsvkdcXvTVGZtzXw-BztilC0y71o0jGa5YLc4Fgl-stvm_h38wa79ha9d3KABZQPPATP4Yi97gYtuwyhZhdHJN0rTNXkF12enVyfnvK-5wE0uVMetRkCSxqktUvwQM0xJCFA6CoWtdV7ZxAltskpkRkldFlYJ4gR0RtciNkW6AxtN27g3wERiq0roWtoa3RCdVoW0hZHo4NQaNVNGcDj-47N-5ixmIepMzf5RUARiUMrM9PzlVEbjx7pHPoyPzAN5xzrhHa_pURLbsL1QEewNqr_XzXE4RvB-vI1Tk85bysa1S5JBdIfwTGXrZLSQkmBcBK_DsFp1gNjRpJBv13dgF56gQrMQGLcHG93d0r1DpNRV-3464Lc-ifdh8_h08u07Xr98nX6e_AX_Ygvd
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9RAEB7KFVEQ0Wo1WnUFfREX9zabZPMgUrXl-usQaaFvabK7wYIkZy-H9sF_yb_RmWySq4j31qeDzSS3ZHZnvsnOfAPwUpki10mpORU5clXmkqehC7lNkzCKtXRF25LlaBpPTtT-aXS6Br_7WhhKq-xtYmuobW3oG_nbcYyxCsUz4_ez75y6RtHpat9Cwy-LA3f5A0O2-bu9T6jfV1Lu7hx_nPCuqwA3sUgabjW63HAcWgzlbUrcJzlhHOUo2bPUcWGlE9pEhYhMonSe2kQQ650zuhRjQ-RLaPLXVYihzAjWP-xMP39Z0vzKtiUf4hbBZax1f47aklTjII1hSINegbzZks3hL6_oEyP_D3lb17d7F-50mJVt-0V2D9ZctQE3fBfLyw247T_9MV_RdB9-oc2hVHdn2eyC2MTJeLC6ZG0FCdtmVJ8ya2o0xWYxZ-e4-gnwsvPq6hX8w6b-iY-df0WTzXpmBWbwwa3sPrr5ilF5DKOzdpSmX_kATq5FH5swqurKPQImpC0KoUtlSwx8dFikyqZGYUhVatRMHsCb4Y1n3V6dZz7PLcn-UVAAoldKZjrGdGrc8W3VLa-HW2aeLmSV8Gar6UESx3A8TQLY6lV_ZZrDBgjgxXAZjQGd8OSVqxckg3gSAWESrZLRQikCjgE89MtqOQHiY1NCPV49gedwc3J8dJgd7k0PnsAtVG7k0_K2YNRcLNxTxGlN8azbHAzOrns__gFLdEPR
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Na9VAEB9KRRFEtFobrbqCXsTQTbLJbg5FivXRDy0eLLxbTPYDCyV59uWhPfiP-dd1JpvkVcR36ymwmSSbzM5XduY3AK-FrkolnQqpyDEUrozDPLFJaHKZpJmKbdW1ZPl8kh2ciqNpOl2DP0MtDKVVDjqxU9Sm0fSPfCfKMFaheCbacX1axJf9yfvZj5A6SNFO69BOwy-RY3v5E8O3-e7hPvL6TRxPPn79cBD2HQZCnXHZhkah-U2ixGBYb3LCQSnJ3xGWEj-dyioTW650WvFUS6HK3EhOCHhWK8cjTUBMqP5v4WtFJGNyKpeAv3HXnA89GB7GmVLDjmoHV42DNIbBDdoHsmtLXIe_7KNPkfy_89sZwckDuN97r2zPL7eHsGbrDbjt-1lebsA9_xOQ-dqmR_AbtQ8lvVvDZheEK05qhDWOdbUkbI9RpcqsbVAp68WcnaEckOvLzurrZ_CBbfMLbzv_jsqbDRgLTOONO9ojNPg1o0IZRrvuSE3H-DGc3gg3NmG9bmq7BYzHpqq4csI4DIFUUuXC5FpgcOUUcqYM4N34xYteaueFz3iTxT8MCoAPTCl0j51OLTzOV13ydrxk5oFDVhFvdpweKXEMx3MZwPbA-mvTHEUhgFfjaVQLtNdT1rZZEA16lugaynQVjeJCkAsZwBO_rJYTIGQ2wcXT1RN4CXdQCotPhyfHz-Au8jb1-XnbsN5eLOxzdNja6kUnGQy-3bQoXgFVWEah
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+prevalence+of+group+A+streptococcus+isolates+in+streptococcal+toxic+shock+syndrome+cases+in+Japan+from+2010+to+2012&rft.jtitle=Epidemiology+and+infection&rft.au=Ikebe%2C+T&rft.au=Tominaga%2C+K&rft.au=Shima%2C+T&rft.au=Okuno%2C+R&rft.date=2015-03-01&rft.eissn=1469-4409&rft.volume=143&rft.issue=4&rft.spage=864&rft_id=info:doi/10.1017%2FS0950268814001265&rft_id=info%3Apmid%2F25703404&rft.externalDocID=25703404
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-2688&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-2688&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-2688&client=summon